There’s been this dream for decades. What if we could just print out an entire gene directly, one base at a time? —Daniel Lin-Arlow, Ansa Biotechnologies As scientists set their sights on cell and ...
DUBLIN--(BUSINESS WIRE)--The "Oligonucleotide Synthesis Market: Forecast by Oligo Length, Application, Category, Type, Product, and Region, with Executive and Consultant Guides" report has been added ...
The "Oligonucleotide Synthesis Market Industry Trends and Global Forecasts to 2035: By Application Area, Type of Product Synthesized, Type of Oligonucleotide Synthesized, Scale of Operation, ...
The "Oligonucleotide Synthesis Market: Industry Trends and Global Forecasts, Till 2035 - Application Area, Type of Product Synthesized, Type of Oligonucleotide Synthesized, Scale of Operation, ...
Therapeutic oligonucleotides act on different stages of pathological gene expression. Standard schematic of oligonucleotide activities in pathogenesis disease progression. Decoys bind to transcription ...
The global oligonucleotide CDMO market is poised for growth driven by the rising clinical pipeline of RNA-based therapies, increased mRNA therapeutic adoption, and biotech firms outsourcing to reduce ...
Oligo Factory’s new low-scale synthesis capability gives researchers the flexibility to order single oligos or small prototype batches, at volumes as low as 50 nmol with the same speed, service, and ...
Oligos are playing a crucial role in driving the progress of modern drug development. Listen to nucleic acid synthesis expert Lina Borozdina deliver a complete class on oligo synthesis starting from ...
HIGH THROUGHPUT: PE Applied Biosystems’ ABI 394 DNA/RNA Synthesizer is controlled by a Macintosh computer. Polypeptides (proteins) and polynucleotides (DNA/RNA) are the two essentials of organic life.
During an oral Spotlight Presentation, Codexis unveiled the successful end-to-end enzymatic synthesis of an entire approved siRNA therapeutic asset, inclisiran. Codexis enzymatically synthesized the ...
REDWOOD CITY, Calif., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, today announced data from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results